Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Eur J Heart Fail
; 24(10): 1805-1812, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36073143
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Diabetes Mellitus, Type 2
/
Heart Failure
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Eur J Heart Fail
Journal subject:
CARDIOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom